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Abstract: Reverse gyrase introduces positive supercoils to circular DNA and is implicated in genome
stability maintenance in thermophiles. The extremely thermophilic crenarchaeon Sulfolobus encodes
two reverse gyrase proteins, TopR1 (topoisomerase reverse gyrase 1) and TopR2, whose functions in
thermophilic life remain to be demonstrated. Here, we investigated the roles of TopR1 in genome
stability maintenance in S. islandicus in response to the treatment of methyl methanesulfonate
(MMS), a DNA alkylation agent. Lethal MMS treatment induced two successive events: massive
chromosomal DNA backbone breakage and subsequent DNA degradation. The former occurred
immediately after drug treatment, leading to chromosomal DNA degradation that concurred with
TopR1 degradation, followed by chromatin protein degradation and DNA-less cell formation. To
gain a further insight into TopR1 function, the expression of the enzyme was reduced in S. islandicus
cells using a CRISPR-mediated mRNA interference approach (CRISPRi) in which topR1 mRNAs were
targeted for degradation by endogenous III-B CRISPR-Cas systems. We found that the TopR1 level
was reduced in the S. islandicus CRISPRi cells and that the cells underwent accelerated genomic DNA
degradation during MMS treatment, accompanied by a higher rate of cell death. Taken together,
these results indicate that TopR1 probably facilitates genome integrity maintenance by protecting
DNA breaks from thermo-degradation in vivo.
Keywords: reverse gyrase; Sulfolobus; MMS; genomic DNA breakage; genomic DNA degradation;
CRISPRi approach
1. Introduction
DNA topoisomerases impose changes to the topological states of circular DNA and play
important roles in DNA replication, recombination, and repair as well as in RNA transcription [1,2].
Thermophiles encode a unique type of topoisomerase named reverse gyrase (TopR) that introduces
positive supercoils to circular DNAs [3]. Because reverse gyrase is the only protein that is exclusively
conserved in thermophilic organisms, the enzyme has been implicated in genome stability maintenance
in thermophiles [4]. Indeed, genetic studies in Thermococcus kodakaraensis, a hyperthermophilic
euryarchaeon, show that growth of cells lacking TopR enzyme is significantly retarded at high
temperatures (from 65 to 90 ◦C) [5]. Further, crenarchaea encode two TopR proteins, but attempts to
isolate TopR deletion mutants from S. islandicus Rey15A was not successful [6], suggesting an essential
function for these enzymes in this crenarchaeon. Therefore, TopR enzymes must have important roles
in thermophilic life.
Extremely thermophilic organisms have to deal with accelerated levels of spontaneous
decomposition of DNA at high temperatures, including deamination of cytosine and base hydrolysis
(usually depurination) [7–9]. These naturally occurring DNA lesions often lead to the formation of
apurinic/apyrimidinic (AP) sites, which eventually yields single strand DNA breaks (SSBs) [7–9].
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Likewise, base alkylation agents, such as methyl methanesulfonate (MMS), generate DNA lesions
that can also be converted to AP sites and SSBs [10]. If not repaired in a timely fashion, AP sites and
SSBs induce collapse of DNA replication, giving rise to double strand DNA breaks (DSBs). DSBs are a
more severe type of DNA lesion that must be repaired by homologous recombination repair (HRR), an
energy-consuming pathway [11,12]. As a result, severe DSB damage on chromosomal DNA often leads
to cell death. Therefore, one of the great challenges in thermophilic life is to deal with numerous DNA
lesions that result from spontaneous DNA decomposition in order to prevent the formation of DSBs.
Since DNA lesions produced by MMS treatment must be repaired in a similar fashion as
DNA lesions generated from spontaneous base decomposition in DNA, MMS treatment provides
a useful means for investigating DNA damage repair mechanisms in thermophilic organisms.
Indeed, investigation on the effect of MMS on genome integrity maintenance in Sulfolobus solfataricus
has revealed that TopR1 is subjected to degradation upon a lethal MMS treatment and that
MMS-induced TopR1 degradation coincides with genomic DNA degradation [13]. Moreover, it has
been shown that the Archaeoglobus fulgidus TopR binds to DNA nicks in vitro and inhibits heat-induced
degradation of nicked DNA, and the DNA protection mechanism is independent of supercoiling [14].
This raises an interesting question as to whether TopR proteins could protect damaged DNA from
thermo-degradation in vivo.
In the article, we employed S. islandicus, a genetic model for which very versatile genetic tools have
been developed [15], to investigate the function of TopR1 in genome integrity maintenance. We found
that MMS treatment induced a series of events including: (a) massive breaks on the sugar-phosphate
backbone of genomic DNA, (b) gradual DNA content reduction and TopR1 degradation, and (c)
DNA-less cell formation and chromatin protein degradation. Moreover, we constructed a TopR1
knockdown strain (pKD-topR1/E233S1) with a CRISPR-based RNA interference tool (CRISPRi) [16].
The strain exhibits a higher sensitivity to MMS and an early onset of DNA degradation during MMS
treatment, indicating that TopR1 protects DNA breaks from thermo-degradation in vivo.
2. Results
2.1. Determination of Moderate and Lethal Dosages of Methyl Methanesulfonate (MMS) for S. islandicus
To investigate the effects of MMS on S. islandicus, exponentially growing S. islandicus cultures
were treated with 0.6, 1.3, or 2.6 mM of MMS, and the treated samples were analyzed for culture
growth and cell viability. While 0.6 mM MMS did not exert any apparent effect on culture growth
(data not shown), 1.3 mM and 2.6 mM MMS yielded growth retardation to the S. islandicus. While a
strong growth inhibition was observed for the 2.6 mM MMS-treated culture, since the absorbance at
600 nm (A600) of the culture stopped increasing immediately after drug addition, only a moderate
growth inhibition was attained by the 1.3 mM MMS-treated culture (Figure 1). Furthermore, in the
2.6 mM MMS-treated culture, colony formation units (CFU) declined by more than 500-fold in the first
30 min of drug treatment, and cell viability did not increase in the following 24 h of incubation. In
contrast, about a 50% drop in cell viability was observed for the 1.3 mM MMS-treated culture in the
first 30 min, and the cell viability started to increase 2 h after drug treatment (Figure 1). Therefore,
the two drug concentrations (1.3 and 2.6 mM) represent a moderate and a lethal dosage of MMS for
exponentially growing S. islandicus cells, respectively.
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Figure 1. Exponential phase cultures were treated with 1.3 mM and 2.6 mM methanesulfonate (MMS), 
respectively. The cultures without any treatment were also grown at the same time as control (CK). 
The optical density (left panel) and cell viability (right panel) were analyzed during the treatment at 
indicated time points. The data are representative of three independent replicates. (CK, black squares; 
1.3 mM, white squares; 2.6 mM, black triangles). OD, the optical density measured at a wavelength 
of 600 nm; CFU, colony formation unit. 
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prepared from cell samples collected during the MMS treatments and analyzed by pulsed field gel 
electrophoresis (PFGE). As shown in Figure 2, whereas the circular chromosomal DNA of untreated 
cells was retained in the loading wells over the 24 h incubation, 1.3 and 2.6 mM of MMS induced the 
accumulation of considerable amounts of genomic DNA fragmentation, which peaked at 15 min after 
drug treatment, indicating that MMS immediately induced extensive DNA backbone breaks on the 
chromosome (Figure 2). Noticeably, the higher dosage of MMS yielded more and shorter DNA 
fragments than the moderate dose, indicating that the number of DNA backbone breaks is correlated 
to MMS dosage, and, furthermore, a DNA band close to the loading well which could correspond to 
the linear chromosomal DNA is present in 1.3 mM MMS-treated samples but absent from 2.6 mM 
MMS-treated samples. Subsequently, the intensity of DNA fragments gradually declined from 2 h in 
both 1.3 and 2.6 mM MMS treatment. Noticeably, from 6 to 24 h during 1.3 mM MMS treatment, most 
genomic DNA was retained in the loading wells, similar to that of the untreated samples, suggesting 
reestablishment of genome integrity after the repair of DNA breaks during the moderate treatment. 
 
Figure 2. Pulsed field gel electrophoresis (PFGE) analysis of total DNA from untreated culture (CK) 
and the cultures treated with 1.3 mM and 2.6 mM MMS. Total DNA from about 4 × 108 cells was 
analyzed for each sample. DNA fragments are visible below the wells in treated samples. 
Figure 1. Exponential phase cultures were treated with 1.3 mM and 2.6 mM methanesulfonate (MMS),
respectively. The cultures without any treatment were also grown at the same time as control (CK).
The optical density (left panel) and cell viability (right panel) were analyzed during the treatment at
indicated time points. The data are representative of three independent replicates. (CK, black squares;
1.3 mM, white squares; 2.6 mM, black triangles). OD, the optical density measured at a wavelength of
600 nm; CFU, colony formation unit.
2.2. MMS Treatment Yields Immediate Genomic DNA Breakage and Subsequent DNA Degradation in
S. islandicus
To reveal whether and how MMS induces genome instability in Sulfolobus, total DNAs were
prepared from cell samples collected during the MMS treatments and analyzed by pulsed field gel
electrophoresis (PFGE). As shown in Figure 2, whereas the circular chromosomal DNA of untreated
cells was retained in the loading wells over the 24 h incubation, 1.3 and 2.6 mM of MMS induced
the accumulation of considerable amounts of genomic DNA fragmentation, which peaked at 15 min
after drug treatment, indicating that MMS immediately induced extensive DNA backbone breaks on
the chromosome (Figure 2). Notic ably, the higher dosag f MMS yielded more and sh rter DNA
fragments than the moderate dose, indica i g that the numb r of DNA backbone breaks is correlated
to M S dosag , and, furthermor , a DNA band close to the loading well which could correspond
to the linear chromosomal DNA is present in 1.3 mM MMS-treated samples but absent from 2.6 mM
MMS-treated samples. Subsequently, the intensity of DNA fragments gradually declined from 2 h in
both 1.3 and 2.6 mM MMS treatment. Noticeably, from 6 to 24 h during 1.3 mM MMS treatment, most
genomic DNA was retained in the loading wells, similar to that of the untreated samples, suggesting
reestablishment of genome integrity after the repair of DNA breaks during the moderate treatment.
Int. J. Mol. Sci. 2017, 18, 1340 3 of 13 
 
 
Figure 1. Exponential phase cult res we  treated ith 1.3 mM and 2.6 mM methanesulfonate (MMS), 
res ectively. The cultures without any treatment were also grown at the same time as control (CK). 
The optical density (left panel) and cell viability (right panel) were analyzed during the tre tment t 
indicated time points. The data are representative of thr e independent replic tes. (CK, black squares; 
1.3 mM, white squares; 2.6 mM, black triangles). OD, the optical density measured at a wavelength 
of 600 nm; CFU, colony formation unit. 
2.2. MMS Treatment Yields Immediate Genomic DNA Breakage and Subsequent DNA Degradation in  
S. islandicus 
To reveal whether and ho  MMS induces genome instability in Sulfolobus, total DNAs were 
prepared from cell samples collected during the MMS treatments and analyzed by pulsed field gel 
electrophoresis (PFGE). As shown in Figur  2, whereas the circul r chromosom l DNA of u treated 
cells was retained i  the loading wells over the 24 h incubation, 1.3 and 2.6 mM of MMS induced the 
accumulation of considerable amounts of genomic DNA fragmentation, which peaked at 15 min after 
drug treatment, indicating that MMS immediately induced extensive DNA backbone breaks on the 
chromosome (Figure 2). Noticeably, the higher dosage of MMS yielded more and shorter DNA 
fragments than the moderate dose, indicating that the number of DNA backbone breaks is correlated 
to MMS dosage, and, furthermore, a DNA band close to the loading well which could correspond to 
the linear chro osomal DNA is present in 1.3 mM MMS-treated samples but absent from 2.6 mM 
MS-treated samples. Subsequently, the intensit  f  frag ents gradually declined from 2 h in 
both 1.3 and 2.6 mM MMS treatment. otic l ,   t  4 h during 1.3 mM M S treatment, most 
genomic DNA was retained in the loading ll   t  that of the untreated samples, uggesting 
reestablishment of genome integrity after the re i    s during the moderate treatment. 
 
Figure 2. Pulsed field gel electrophoresis (PFGE) analysis of total DNA from untreated culture (CK) 
and the cultures treated with 1.3 mM and 2.6 mM MMS. Total DNA from about 4 × 108 cells was 
analyzed for each sample. DNA fragments are visible below the wells in treated samples. 
Figure 2. Pulsed field gel electrophoresis (PFGE) analysis of total DNA from untreated culture (CK)
and the cultures treated with 1.3 mM and 2.6 mM MMS. Total DNA from about 4 × 108 cells was
analyzed for each sample. DNA fragments are visible below the wells in treated samples.
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Next, we set out to analyze the DNA content distributions in the cells of MMS-treated cultures by
flow cytometry (Figure 3). The results showed that DNA content distributions of untreated samples
remained unchanged in the first 9 h of incubation. Then, the population of G1 and S phase cells
decreased at 24 h, which could reflect that the cells were in a late exponential stage at the time. For the
moderate MMS treatment, G1 and S phase cells were accumulated in the first 6 h of incubation, and
a small fraction of DNA-less cells appeared at 9 h. By 24 h after MMS addition, most cells showed
a DNA content of one or more than one chromosomes. Together, these data suggest that, while the
majority of cells were recovered from MMS-mediated DNA damage, some cells underwent cell death.
In the lethal MMS treatment, however, the DNA content distribution remained the same in the first
1 h, suggesting that although MMS induce immediate DNA backbone breakage, the DNA breaks were
protected from degradation at this time. Then, DNA content gradually decreased as the DNA content
peaks moved leftwards from 1 to 4 h during the drug treatment, and eventually a peak corresponding
to DNA-less cells occurred at 6 h. Additionally, at 24 h, most cells became DNA-less cells. Thus, we
concluded that lethal MMS-induced DNA breaks eventually lead to chromosomal DNA degradation,
while DNA breaks after a moderate MMS treatment are largely repairable such that most cells are
eventually recovered from the MMS-mediated DNA damage.
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2.3. MMS-Induced TopR1 Degradation is Prior to Chromatin Protein Degradation 
To investigate the dynamics of chromatin architecture proteins during MMS-induced genomic 
DNA degradation in S. islandicus, we analyzed the level of TopR1, Sul7, and Cren7 in S. islandicus 
cells by western blot during 1.3 and 2.6 mM MMS treatment (Figure 4). In the moderate MMS 
Figure 3. (A) Exponential phase cultures were treated with 0 (CK), 1.3 mM or 2.6 mM MMS, and the
DNA content distributions were analyzed by flow cytometry at indicated time points; (B) Selected
results from indicated time points (0 h, blue; 2 h, red; 24 h, green) are directly compared to better
show typical changes of DNA content distributions during MMS treatment. Dashed lines marked
with “L”, “1”, and “2” indicate DNA-less cells and cells containing one or two copies of genomic DNA
respectively. X axis: DNA content; Y axis: cell count. Both X axis and Y axis are shown in linear scale.
2.3. MMS-Induced TopR1 Degradation is Prior to Chromatin Protein Degradation
To investigate the dynamics of chromatin architecture proteins during MMS-induced genomic
DNA degradation in S. islandicus, we analyzed the level of TopR1, Sul7, and Cren7 in S. islandicus cells
by western blot during 1.3 and 2.6 mM MMS treatment (Figure 4). In the moderate MMS treatment,
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Cren7 and Sul7 contents remained more or less the same in the cells whereas TopR1 level decreased
from 2 to 6 h. Then, at 9 h after drug addition, TopR1 level started to increase, indicative of full recovery
of the cells from the MMS-mediated DNA damage. In the lethal MMS treatment, after the onset of
TopR1 degradation at 2 h after drug addition, the level of the protein continuously decreased along
with the incubation, which coincided with cellular DNA content reduction. Finally, cellular TopR1
was no longer detectable after 19 h of drug treatment. In addition, lethal MMS treatment also induced
chromatin protein degradation at 6 h. The sequential degradation of TopR1 and chromatin proteins
suggests that they play different roles in genome stability maintenance in this archaeon.
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At 24 h after treatment, 1.3 and 2 mM MMS induced a moderate increase of DNA-less cells
in the pKD-topR1/E233S1 culture relative to that of pSeSD1/E233S1, while 2.6 mM MMS induced
almost 100% DNA-less cells for both strains (Figure 5C). To further reveal the roles of TopR1 in the
response to MMS, we compared DNA content distributions between the two strains before DNA-less
cell formation, and the results show that the DNA content in pKD-topR1/E233S1 cells was less than
that in pSeSD1/E233S1 from 3 h to 9 h during 2 mM MMS treatment and at 3 h during 2.6 mM MMS
treatment (Figure 5D), indicating that the cells with a reduced TopR1 level underwent accelerated
genomic DNA degradation during MMS treatment.
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Previous research showed that 0.7 mM MMS is a lethal dosage for S. solfataricus cells, which is
much lower than the let al dosage (2.6 mM) for S. islandicus identified in this work. To verify the
results, compared the MMS sensitivity of S. solfataricus and S. island cus. The two species wer
Int. J. Mol. Sci. 2017, 18, 1340 7 of 13
grown and treated with MMS in the same conditions, and cell viability and DNA content distributions
of the treated samples were analyzed. First, during 1.3, 2, and 2.6 mM MMS treatment, S. solfataricus
exhibited about 4, 23, and over 100-times lower survival rate than that of S. islandicus, respectively,
confirming that S. solfataricus is indeed more sensitive to MMS than S. islandicus (Figure 6A). Further,
the reduction of DNA content in S. solfataricus was also faster than that in S. islandicus, indicating
that MMS induced more intensive DNA degradation in S. solfataricus (Figure 6B and Figure S1). We
also noticed that most S. solfataricus cells became DNA-less cells after treatment of 2 mM MMS in this
study, which is much higher than the lethal dosage for S. solfataricus cells reported previously [13].
The difference between the two studies could be due to different growth and treatment conditions in
experiments, or unknown strain differences.
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Figure 6. TopR1 was bound to the chromatin part in S. islandicus. (A) S. islandicus Rey15A and S.
solfataricus P2 cultures were treated with 0, 1.3, 2, or 2.6 mM MMS, and cell viability was analyzed
after 2 h of treatment; (B) comparison of cellular DNA content of S. islandicus Rey15A (blue line) and S.
solfataricus P2 (red line) during MMS treatment. Selected samples from Supplementary Figure S1 are
shown, and the MMS concentration and treatment time are indicated; (C) western blots analysis of the
subcellular location of TopR1 in S. islandicus Rey15A and S. solfataricus P2. TP, total protein; P, pellet
(chromatin-rich fraction); S, supernatant (cytoplasm fraction). Antiserum against PCNA3 was used as
a loading control. The asterisk represents p values less than 0.05. The p value was calculated by paired
t test.
It was also reported that SsoTopR1 mainly exists in the cytoplasm of S. solfataricus and is not
recruited into chromosomes during MMS treatment [13]. Further, AfuTopR1 binds to DNA nicks to
protect nicked DNA from thermo-degradation in vitro [14]. Therefore, we analyzed the subcellular
location of TopR1 in S. islandicus cells as well as in S. solfataricus cells. Cell lysates (total protein, TP)
of S. solfataricus and S. islandicus were fractionated into soluble supernatant (S, cytoplasm fraction)
and pellet fractions (P, DNA-rich fraction) as previously described [17]. The abundance of TopR1 and
PCNA3 in TP, S, and P fractions was analyzed by western blot. As shown in Figure 6C, while most
TopR1 in S. solfataricus existed in the cytoplasm fraction, more than a half of TopR1 in S. islandicus was
bound to chromosomes, suggesting that the chromosome-associated TopR1 may be responsible for the
higher resistance of S. islandicus to MMS.
We further analyzed the dynamics of TopR1 protein from the cytoplasm fraction and
chromatin-rich fraction during MMS treatment in S. islandicus Rey15A. Treated S. islandicus Rey15A
cells were collected and fractionated as previously described [17], and levels of TopR1 were analyzed
in each fraction. The results indicate that TopR1 levels were reduced in both cytoplasm fraction and
chromatin-rich fraction (Figure 7), suggesting that MMS-induced degradation occurs to TopR1 from
both fractions in S. islandicus Rey15A.
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3. Discussion
In this study, we analyzed the effects of MMS on the genome integrity of S. islandicus, a
thermophilic crenarchaeon and investigated the functions of TopR1 in genome stability maintenance.
Several lines of experimental evidence indicate that SisTopR1 protects MMS-induced DNA breaks
from thermo-degradation in a chromosome-associated manner in vivo.
First, we have demonstrated that MMS treatment immediately induces genomic DNA breakage
in Sulfolobus. MS does not directly introduce DNA breaks to genomic DNA in yeast and mammalian
cells; however, MMS-induced DNA lesions could be converted into DNA breaks by base excision
repair (BER) processing or DNA replication collapse [10]. In addition, MMS-induced DNA lesions are
heat-labile in vitro and are converted to single stranded DNA breaks (SSBs) at 50 ◦C; two close SSBs
will results in the formation of a DSB [18]. Therefore, the DNA breaks observed in this study can be
derived from two main sources: (i) thermo-degradation of MMS-induced lesions at the physiologic
growth temperature of S. islandicus and (ii) processing of the lesions by BER pathway. Considering the
rapid occurrence of genomic DNA breakage, it is more likely that thermo-degradation of MMS-induced
lesions constitutes the main source of MMS-induced DNA breaks. As a result, this suggests that MMS
can function as a direct DNA break agent in thermophiles.
Second, lethal MMS-induced genomic DNA degradation is evidenced by the decline of DNA
fragments as shown by PFGE analysis and gradual reduction of cellular DNA content as shown
in flow cytometry analysis. The degradation could be directly triggered by MMS-induced massive
SSBs, since an SSB can accelerate thermo-degradation of genomic DNA in vitro: first, supercoiled
DNA is not likely to be denatured, while nicks initiate dsDNA denaturation [7]; second, the exposed
ssDNA is even more fragile, exhibiting a much higher depurination rate and breakage rate, leading to
dsDNA breakage and further degradation [8,9]. More strikingly, we demonstrate that even though
MMS induces immediate genomic DNA backbone breakage, cellular DNA content does not start
to reduce until TopR1 degradation occurs (Figures 2–4), supporting the previous hypothesis that
TopR functions in protecting damaged DNA from degradation [13,14]. Further, chromatin protein
degradation occurs after TopR1 degradation and coincides with DNA-less cell formation, a common
cell death consequence of the treatment of different DNA damage agents (submitted). The sequential
degradation of TopR1 and chromatin proteins suggest that after MMS introduces DNA breaks, TopR1
is first subjected to degradation, leading to genomic DNA degradation, which triggers a cell death
signal and induces chromatin protein degradation and DNA-less cell formation. The findings also
suggest that TopR1 and chromatin proteins play distinct roles in protecting genomic DNA. We reason
that TopR1 might bind to the regions that are loosely compacted or not compacted by chromatin
proteins. Nevertheless, the detailed mechanisms for MMS-induced DNA degradation and the roles of
these chromatin architecture proteins remain to be clarified.
Lastly, the roles of TopR1 in genome stability maintenance have been demonstrated by CRISPRi
of TopR1 expression. The strain with decreased TopR1 levels (pKD-topR1/E233S1) is more sensitive
to MS treatment than the reference strain (pSeSD1/E233S1). Further, MMS-induced DNA
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degradation is strongly accelerated in pKD-topR1/E233S1, suggesting that damaged DNA is prone
to thermos-degradation upon an insufficiency of TopR1. The data, together with the fact that MMS
induces SSBs at high temperature in vitro [18] and rapid genomic DNA breakage in Sulfolobus (Figure
2), indicate that TopR1 functions in the thermo-protection of SSBs in vivo. Conceivably, TopR1 should
also protect the DNA breaks derived from spontaneous DNA hydrolysis at high temperatures, which
could represent a general function for reverse gyrase in thermophiles.
In addition, knockdown of TopR1 by CRISPRi in S. islandicus cells also leads to a moderate
accumulation of S phase cells. This either suggests that (1) TopR1 has a role in DNA replication or
that (2) the reduced level of protection for spontaneous genomic DNA breaks in TopR1-CRISPRi cells
yields DNA replication fork collapse. Indeed, it has been suggested that TopR1 is involved in cell
duplication in S. solfataricus [19]. On the other hand, we observed that moderate MMS treatment
also induces accumulation of S phase cells (Figure 3), supporting that unrepaired DNA breaks arrest
DNA replication in TopR1-CRISPRi cells. Currently, it is not possible to distinguish the two possible
mechanisms experimentally.
Moreover, the association of SisTopR1 to chromatin and the higher MMS resistance of S. islandicus
suggest that the DNA protection role of TopR1 is related to its association to DNA. The hypothesis
is consistent with the fact that AfuTopR protects nicked DNA possibly by binding to the breaks
in vitro [14]. On the other hand, even though TopR1 proteins from S. islandicus and S. solfataricus exhibit
high sequence similarity (Figure S2), most SsoTopR1 protein exists in the cytoplasm fraction. Further,
SsoTopR1 is recruited to the chromatin-rich fraction upon ultraviolet (UV) treatment, suggesting
translocation of TopR1 upon DNA damage [17]. A similar translocation mechanism might be adopted
in S. islandicus under normal growth conditions.
TopR1 degradation has been proved to be very specific. It was only observed during MMS
treatment, while other stressful conditions, including hydroxyurea (HU) and UV treatment, fail to
induce the phenomena [13], even though UV also induces DNA breaks and arrests DNA replication in
S. solfataricus [20]. We reason that MMS and UV induce different types of DNA breaks: MMS-induced
heat-labile DNA lesions are immediately converted to massive SSBs at the physiologic growth
temperature of Sulfolobus, while UV-induced DNA lesions may be converted to DNA breaks by
DNA replication fork collapse. The findings hint that TopR1 is specifically induced by massive SSBs.
Nevertheless, the question regarding the biological meaning of TopR1 degradation remains to be
answered. Possibly, TopR1 degradation represents an important step in the archetypal programmed
cell death, as hypothesized previously [13], such that TopR1 degradation results in thermo-degradation
of damaged DNA, leading to cell death. However, we have shown that TopR1 is degraded to a
similar extent from 2 to 6 h in the moderate and the lethal MMS treatment (Figures 4 and 5A). The
difference between the treatments is that TopR1 level recovered from 6 to 24 h during moderate
MMS treatment but continuously decreased upon lethal MMS treatment. Therefore, we assume
that TopR1 degradation also plays a role in DNA repair to increase the local access to DNA repair
machineries of the damaged site upon moderate treatment similar to that in Eukaryotes [21,22]. Indeed,
TopR-coated dsDNA exhibits limited accessibility in vitro [14]. Furthermore, the two hypotheses are
not mutually exclusive: upon moderate MMS treatment, TopR1 degradation increases the local access
to DNA repair machineries and facilitates DNA repair and cell survival; upon lethal MMS treatment,
DNA repair machineries may fail to repair massive DNA breaks in a timely fashion. As a result, the
decrease of cellular TopR1 content would result in exposure of more DNA backbone breaks from
thermo-degradation, leading to cell death.
4. Materials and Methods
4.1. Construction of the TopR1 Knockdown Strain
The strategy for construction of the TopR1 (gene locus: SiRe_1581) knockdown plasmid was
similar to that described in [16]. Specifically, we chose two unique sequence regions preceded
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by a GAAAG motif at the 5′ end from the antisense strand as spacers to abolish DNA cleavage
activity [23]. The oligonucleotides for them are shown in the Supplementary Table S1. The spacer
fragments were prepared by annealing and extension of each pair of oligonucleotides. Then, the
two spacer fragments were mixed and the mixture was used as a template for further amplification
with S1-forward and S2-rev-SalI as primers. The obtained fragments were inserted into pSeSD1, an
expression vector widely used in S. islandicus [24], between StuI and SalI. Then, the generated plasmid
was transferred into Escherichia coli DH5α, and the colonies were screened by sequencing. At last,
a plasmid containing one copy of each spacer was transferred into S. islandicus E233S1 and three
transformants (pKD-topR1/E233S1) were picked and grown for further analysis. In the meantime,
pSeSD1 was also transferred into the genetic host as control (pSeSD1/E233S1).
4.2. Culture Growth and Treatment
The genetic host, S. islandicus E233S1, was grown in SCVU medium, containing 0.2% sucrose (S),
0.2% Casamino acids (C), 5 µL/mL of vitamin mixture solution (V) and 20 µg/mL uracil (U), as describe
previously [25], while other stains, including pSeSD1/E233S1, pKD-TopR1/E233S1, S. islandicus
Rey15A, and S. solfataricus P2 were grown in SCV medium that lacks uracil compared to SCVU. Before
treatment, the cultures were grown at exponential phase for at least 72 h, and then early exponential
phase cultures (The optical density at a wavelength of 600 nm is about 0.2) were supplemented with
MMS up to the indicated concentrations. Aliquots without the drug were set as controls. During
treatment, the cultures were grown at 78 ◦C in the dark and the samples for OD measuring, cell
viability assays, flow cytometry, PFGE, and western blot were taken at indicated time points.
4.3. Cell Viability
Cells were collected from 1 mL of untreated or treated cultures by centrifugation and resuspended
in 1 mL of fresh medium of the same composition. Then, resuspended cells were diluted by 102
and 104 times, and for each dilution as well as the original cell suspension, 10 µL and 100 µL of cell
suspension were mixed with pre-warmed top layer gel and spread onto SCV plates as previously
described (SCVU for S. islandicus E233S1) [25]. The plates were incubated at 75 ◦C for 6 days;
then, plates with suitable colony densities were selected for colony counting. The cell viability
was determined in three independent experiments.
4.4. Flow Cytometry
To analyze DNA content and cell size distributions, 300 µL of samples was taken from a culture
to which 700 µL of absolute ethanol was added. The samples were stored at 4 ◦C for at least 12 h to
fix cells. Then, fixed cells were collected by centrifugation at 2800 rpm for 20 min and washed with
1 mL of 10 mM Tris-NaCl, pH 7.5, and 10 mM MgCl2. Cells were collected again and resuspended in
140 µL of staining dye containing 40 µg/mL ethidium bromide (Sigma-Aldrich, St. Louis, MO, USA)
and 100 µg/mL mithramycin A (Apollo chemical, Tamworth, UK). Stained cell samples were analyzed
by an Apogee A40 cytometer (Apogeeflow, Hertfordshire, UK) equipped with 405 nm laser. A dataset
of at least 60,000 cells was collected for each sample.
4.5. Western Blot
Cells from 10 mL of the untreated or treated cultures were collected and resuspended in bufferA
(50 mM Tris-NaCl, pH 8.0, 100 mM NaCl). Then, 5× SDS-loading buffer was added into the
solution, followed by heating at 95 ◦C for 10 min, to disrupt the cells. The final volume of the
samples was calculated according to the optical density to make sure that the number of cells for
each line was same. Then, the proteins were separated by sodium dodecyl sulfate polyacrylamide
gel electrophoresis (SDS-PAGE) and transferred to a polyvinylidene difluoride (PVDF) membrane
(Bio-Rad, Hercules, CA, USA) and the membrane was incubated with antibodies for Cren7 [26],
Sul7d [27], TopR1, and PCNA [28]. Afterwards, the membrane was incubated with anti-rabbit
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horseradish peroxidase (HRP) Secondary antibody (Thermo Fisher Scientific, Waltham, MA, USA) and
the enhanced chemiluminescence (ECL) western blot substrate (Thermo Fisher Scientific, Waltham,
MA, USA) was used to detect the signals. The antiserum against TopR1 was raised in rabbits using
purified recombinant TopR1 protein.
4.6. Pulsed-Field Gel Electrophoresis (PFGE)
About 6 × 109 cells (given that 1 mL culture of OD600 = 1.0 contains 109 cells) were collected
from 30 mL of untreated or treated S. islandicus culture by centrifugation. The cells were washed with
50 mL of TEN buffer (50 mM Tris-Cl, pH 8, 50 mM EDTA, pH 8, 100 mM NaCl) and resuspended
in 150 µL prewarmed TEN buffer (37 ◦C). Then, the cell suspension was mixed with 150 µL of 0.8%
low-melting-point agarose (precooled to 37 ◦C) and transferred to a plug mold with 85 µL per well.
After solidification at 4 ◦C for 30 min, the plugs were released from the mold into a 1.5 mL microfuge
tube containing 1 mL of NDS solution (0.5 M EDTA, 0.12% Tris, 0.55 M NaOH, pH 8.5, 1% N-lauroyl
sarcosine sodium salt) and 1 mg/mL proteinase K (Sigma-Aldrich, St. Louis, MO, USA) and incubated
for two days at 30 ◦C. The old proteinase K-containing NDS buffer was replaced by a fresh solution
of the same composition after 1 day’s incubation. The plugs then were washed three times with
NDS and stored at 4 ◦C. For PFGE, about one fourth of a plug was transferred into each well of
an agarose gel, and electrophoresis was conducted with a CHEF-DR III pulsed-field electrophoresis
system (Bio-Rad, Hercules, CA, USA) under the running condition of 3.5 V/cm with the switch time
from 5 to 100 s for 40 h. Then, the gel was stained with a nucleic staining dye SYBR gold (Thermo
Fisher Scientific, Waltham, MA, USA), and the image was captured by using Typhoon FLA 7000 (GE
Healthcare, Chicago, IL, USA).
4.7. Isolation of DNA-Rich Fraction
The procedure to isolate DNA-rich fraction from Sulfolobus was modified from that described
in [29]. Specifically, about 8 × 109 cells from different Sulfolobus species were harvested by
centrifugation, washed with extraction buffer (50 mM Tris-HCl pH 7, 15 mM MgCl2, 50 mM NaCl,
1 mM DTT, 0.4 M sorbitol) and resuspended with 400 µL of the same buffer. Then, half volume
of the cell solution was mixed with 5× SDS-loading buffer (total protein, TP), while the rest was
supplemented with 0.5% Triton X-100, placed on ice for 30 min, and subjected to centrifugation at
13,000 rpm for 10 min at 4 ◦C. The supernatant (S, cytoplasm fraction) derived from the centrifugation
was then mixed with 5× SDS-loading buffer, while the pellet (P, DNA-rich fraction) was resuspended
with 200 µL of extraction buffer and also mixed with 5× SDS-loading buffer. At last, all three fractions
were heated at 95 ◦C for 10 min and 10 µL of each fraction were run on SDS-gels and analyzed by
western blot.
5. Conclusions
Lethal MMS treatment induces immediate genomic DNA breakage, followed by genomic DNA
degradation. The latter co-occurs with TopR1 degradation. Further, cells with a lower TopR1 level are
more sensitive to MMS and undergo accelerated genomic DNA degradation during MMS treatment.
Together, the data indicate that TopR1 could protect DNA breaks from degradation in vivo.
Supplementary Materials: Supplementary materials can be found at www.mdpi.com/1422-0067/18/7/1340/s1.
Acknowledgments: This research was supported by the Danish Council for Independent Research (grant No.
DFF-0602-02196, DFF-1323-00330). Wenyuan Han and Xu Feng are recipients of a PhD studentship from the China
Scholarship Council.
Author Contributions: Wenyuan Han and Qunxin She conceived and designed the experiments; Wenyuan Han
and Xu Feng performed the experiments; Wenyuan Han and Qunxin She analyzed the data and wrote the paper.
All authors have read and approved the final manuscript.
Conflicts of Interest: The authors declare no conflict of interest.
Int. J. Mol. Sci. 2017, 18, 1340 12 of 13
References
1. Champoux, J.J. DNA topoisomerases: Structure, function, and mechanism. Annu. Rev. Biochem. 2001, 70,
369–413. [CrossRef] [PubMed]
2. Wang, J.C. Cellular roles of DNA topoisomerases: A molecular perspective. Nat. Rev. Mol. Cell Biol. 2002, 3,
430–440. [CrossRef] [PubMed]
3. D’Amaro, A.; Rossi, M.; Ciaramella, M. Reverse gyrase: An unusual DNA manipulator of hyperthermophilic
organisms. Ital. J. Biochem. 2007, 56, 103–109. [PubMed]
4. Heine, M.; Chandra, S.B. The linkage between reverse gyrase and hyperthermophiles: A review of their
invariable association. J. Microbiol. 2009, 47, 229–234. [CrossRef] [PubMed]
5. Atomi, H.; Matsumi, R.; Imanaka, T. Reverse gyrase is not a prerequisite for hyperthermophilic life. J. Bacteriol.
2004, 186, 4829–4833. [CrossRef] [PubMed]
6. Zhang, C.; Tian, B.; Li, S.; Ao, X.; Dalgaard, K.; Gokce, S.; Liang, Y.; She, Q. Genetic manipulation in Sulfolobus
islandicus and functional analysis of DNA repair genes. Biochem. Soc. Trans. 2013, 41, 405–410. [CrossRef]
[PubMed]
7. Marguet, E.; Forterre, P. DNA stability at temperatures typical for hyperthermophiles. Nucleic Acids Res.
1994, 22, 1681–1686. [CrossRef] [PubMed]
8. Lindahl, T. Instability and decay of the primary structure of DNA. Nature 1993, 362, 709–715. [CrossRef]
[PubMed]
9. Lindahl, T.; Andersson, A. Rate of chain breakage at apurinic sites in double-stranded deoxyribonucleic acid.
Biochemistry 1972, 11, 3618–3623. [CrossRef] [PubMed]
10. Wyatt, M.D.; Pittman, D.L. Methylating agents and DNA repair responses: Methylated bases and sources of
strand breaks. Chem. Res. Toxicol. 2006, 19, 1580–1594. [CrossRef] [PubMed]
11. Cejka, P.; Mojas, N.; Gillet, L.; Schar, P.; Jiricny, J. Homologous recombination rescues
mismatch-repair-dependent cytotoxicity of SN 1-type methylating agents in S. cerevisiae. Curr. Biol. 2005, 15,
1395–1400. [CrossRef] [PubMed]
12. Nowosielska, A.; Smith, S.A.; Engelward, B.P.; Marinus, M.G. Homologous recombination prevents
methylation-induced toxicity in escherichia coli. Nucleic Acids Res. 2006, 34, 2258–2268. [CrossRef] [PubMed]
13. Valenti, A.; Napoli, A.; Ferrara, M.C.; Nadal, M.; Rossi, M.; Ciaramella, M. Selective degradation of
reverse gyrase and DNA fragmentation induced by alkylating agent in the archaeon Sulfolobus solfataricus.
Nucleic Acids Res. 2006, 34, 2098–2108. [CrossRef] [PubMed]
14. Kampmann, M.; Stock, D. Reverse gyrase has heat-protective DNA chaperone activity independent of
supercoiling. Nucleic Acids Res. 2004, 32, 3537–3545. [CrossRef] [PubMed]
15. Peng, N.; Han, W.; Li, Y.; Liang, Y.; She, Q. Genetic technologies for extremely thermophilic microorganisms
of sulfolobus, the only genetically tractable genus of crenarchaea. Sci. China Life Sci. 2017, 60, 370–385.
[CrossRef] [PubMed]
16. Peng, W.; Feng, M.; Feng, X.; Liang, Y.X.; She, Q. An archaeal crispr type iii-b system exhibiting distinctive
RNA targeting features and mediating dual RNA and DNA interference. Nucleic Acids Res. 2015, 43, 406–417.
[CrossRef] [PubMed]
17. Napoli, A.; Valenti, A.; Salerno, V.; Nadal, M.; Garnier, F.; Rossi, M.; Ciaramella, M. Reverse gyrase
recruitment to DNA after UV light irradiation in Sulfolobus solfataricus. J. Biol. Chem. 2004, 279, 33192–33198.
[CrossRef] [PubMed]
18. Lundin, C.; North, M.; Erixon, K.; Walters, K.; Jenssen, D.; Goldman, A.S.; Helleday, T. Methyl
methanesulfonate (MMS) produces heat-labile DNA damage but no detectable in vivo DNA double-strand
breaks. Nucleic Acids Res. 2005, 33, 3799–3811. [CrossRef] [PubMed]
19. Couturier, M.; Bizard, A.H.; Garnier, F.; Nadal, M. Insight into the cellular involvement of the two reverse
gyrases from the hyperthermophilic archaeon Sulfolobus solfataricus. BMC Mol. Biol. 2014, 15, 18. [CrossRef]
[PubMed]
20. Frols, S.; Gordon, P.M.; Panlilio, M.A.; Duggin, I.G.; Bell, S.D.; Sensen, C.W.; Schleper, C. Response of
the hyperthermophilic archaeon Sulfolobus solfataricus to UV damage. J. Bacteriol. 2007, 189, 8708–8718.
[CrossRef] [PubMed]
Int. J. Mol. Sci. 2017, 18, 1340 13 of 13
21. Ziv, Y.; Bielopolski, D.; Galanty, Y.; Lukas, C.; Taya, Y.; Schultz, D.C.; Lukas, J.; Bekker-Jensen, S.; Bartek, J.;
Shiloh, Y. Chromatin relaxation in response to DNA double-strand breaks is modulated by a novel atm- and
kap-1 dependent pathway. Nat. Cell Biol. 2006, 8, 870–876. [CrossRef] [PubMed]
22. Tsukuda, T.; Fleming, A.B.; Nickoloff, J.A.; Osley, M.A. Chromatin remodelling at a DNA double-strand
break site in Saccharomyces cerevisiae. Nature 2005, 438, 379–383. [CrossRef] [PubMed]
23. Deng, L.; Garrett, R.A.; Shah, S.A.; Peng, X.; She, Q. A novel interference mechanism by a type iiib crispr-cmr
module in Sulfolobus. Mol. Microbiol. 2013, 87, 1088–1099. [CrossRef] [PubMed]
24. Peng, N.; Deng, L.; Mei, Y.; Jiang, D.; Hu, Y.; Awayez, M.; Liang, Y.; She, Q. A synthetic arabinose-inducible
promoter confers high levels of recombinant protein expression in hyperthermophilic archaeon Sulfolobus
islandicus. Appl. Environ. Microbiol. 2012, 78, 5630–5637. [CrossRef] [PubMed]
25. Deng, L.; Zhu, H.; Chen, Z.; Liang, Y.X.; She, Q. Unmarked gene deletion and host-vector system for the
hyperthermophilic crenarchaeon Sulfolobus islandicus. Extremophiles 2009, 13, 735–746. [CrossRef] [PubMed]
26. Guo, L.; Feng, Y.; Zhang, Z.; Yao, H.; Luo, Y.; Wang, J.; Huang, L. Biochemical and structural characterization
of Cren7, a novel chromatin protein conserved among Crenarchaea. Nucl. Acids Res. 2008, 36, 1129–1137.
[CrossRef] [PubMed]
27. Guo, R.; Xue, H.; Huang, L. Ssh10b, a conserved thermophilic archaeal protein, binds RNA in vivo.
Mol. Microbiol. 2003, 50, 1605–1615. [CrossRef] [PubMed]
28. Samson, R.Y.; Xu, Y.; Gadelha, C.; Stone, T.A.; Faqiri, J.N.; Li, D.; Qin, N.; Pu, F.; Liang, Y.X.; She, Q.; et al.
Specificity and function of archaeal DNA replication initiator proteins. Cell Rep. 2013, 3, 485–496. [CrossRef]
[PubMed]
29. Quaiser, A.; Constantinesco, F.; White, M.F.; Forterre, P.; Elie, C. The Mre11 protein interacts with both
Rad50 and the HerA bipolar helicase and is recruited to DNA following gamma irradiation in the archaeon
Sulfolobus acidocaldarius. BMC Mol. Biol. 2008, 9, 25. [CrossRef] [PubMed]
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
